Avidity Biosciences
RNAM
#1852
Rank
A$15.64 B
Marketcap
A$101.25
Share price
0.00%
Change (1 day)
107.17%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: A$15.64 Billion

As of April 2026 Avidity Biosciences has a market cap of A$15.64 Billion. This makes Avidity Biosciences the world's 1852th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026A$15.64 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$212.54 B 1,258.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$150.67 B 863.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$3.00 B-80.82%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$8.01 B-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.21 B-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.14 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.19 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$4.95 B-68.31%๐Ÿ‡บ๐Ÿ‡ธ USA